Arctic Bioscience AS provided revenue guidance for the year 2023. Overall, for the Company they are reducing the expected revenue growth for the full year from 30% to 35% to 15% to 20%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.4 NOK | 0.00% | +6.12% | -0.95% |
03-01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.95% | 24.2M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- ABS Stock
- News Arctic Bioscience
- Arctic Bioscience AS Provides Revenue Guidance for the Year 2023